These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19514039)

  • 1. Combinatorial strategies by marine cyanobacteria: symplostatin 4, an antimitotic natural dolastatin 10/15 hybrid that synergizes with the coproduced HDAC inhibitor largazole.
    Taori K; Liu Y; Paul VJ; Luesch H
    Chembiochem; 2009 Jul; 10(10):1634-9. PubMed ID: 19514039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp.
    Taori K; Paul VJ; Luesch H
    J Am Chem Soc; 2008 Feb; 130(6):1806-7. PubMed ID: 18205365
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and biological evaluation of c7-demethyl largazole analogues.
    Chen F; Gao AH; Li J; Nan FJ
    ChemMedChem; 2009 Aug; 4(8):1269-72. PubMed ID: 19431162
    [No Abstract]   [Full Text] [Related]  

  • 4. Structural basis of the antiproliferative activity of largazole, a depsipeptide inhibitor of the histone deacetylases.
    Cole KE; Dowling DP; Boone MA; Phillips AJ; Christianson DW
    J Am Chem Soc; 2011 Aug; 133(32):12474-7. PubMed ID: 21790156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Preliminary Biological Evaluation of Two Fluoroolefin Analogs of Largazole Inspired by the Structural Similarity of the Side Chain Unit in Psammaplin A.
    Zhang B; Shan G; Zheng Y; Yu X; Ruan ZW; Li Y; Lei X
    Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31163697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis and molecular target of largazole, a histone deacetylase inhibitor.
    Ying Y; Taori K; Kim H; Hong J; Luesch H
    J Am Chem Soc; 2008 Jul; 130(26):8455-9. PubMed ID: 18507379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological characterization of the histone deacetylase inhibitor largazole and C7- modified analogues.
    Souto JA; Vaz E; Lepore I; Pöppler AC; Franci G; Alvarez R; Altucci L; de Lera AR
    J Med Chem; 2010 Jun; 53(12):4654-67. PubMed ID: 20491440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and activity of largazole analogues with linker and macrocycle modification.
    Ying Y; Liu Y; Byeon SR; Kim H; Luesch H; Hong J
    Org Lett; 2008 Sep; 10(18):4021-4. PubMed ID: 18707106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted natural products discovery from marine cyanobacteria using combined phylogenetic and mass spectrometric evaluation.
    Salvador-Reyes LA; Engene N; Paul VJ; Luesch H
    J Nat Prod; 2015 Mar; 78(3):486-92. PubMed ID: 25635943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides.
    Harrigan GG; Luesch H; Yoshida WY; Moore RE; Nagle DG; Paul VJ; Mooberry SL; Corbett TH; Valeriote FA
    J Nat Prod; 1998 Sep; 61(9):1075-7. PubMed ID: 9748368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability.
    Benelkebir H; Marie S; Hayden AL; Lyle J; Loadman PM; Crabb SJ; Packham G; Ganesan A
    Bioorg Med Chem; 2011 Jun; 19(12):3650-8. PubMed ID: 21420302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic routes and biological evaluation of largazole and its analogues as potent histone deacetylase inhibitors.
    Li S; Yao H; Xu J; Jiang S
    Molecules; 2011 Jun; 16(6):4681-94. PubMed ID: 21654576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticolon cancer activity of largazole, a marine-derived tunable histone deacetylase inhibitor.
    Liu Y; Salvador LA; Byeon S; Ying Y; Kwan JC; Law BK; Hong J; Luesch H
    J Pharmacol Exp Ther; 2010 Nov; 335(2):351-61. PubMed ID: 20739454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Largazole Analogues as Histone Deacetylase Inhibitors and Anticancer Agents: An Overview of Structure-Activity Relationships.
    Poli G; Di Fabio R; Ferrante L; Summa V; Botta M
    ChemMedChem; 2017 Dec; 12(23):1917-1926. PubMed ID: 29117473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected Enhancement of HDACs Inhibition by MeS Substitution at C-2 Position of Fluoro Largazole.
    Zhang B; Ruan ZW; Luo D; Zhu Y; Ding T; Sui Q; Lei X
    Mar Drugs; 2020 Jun; 18(7):. PubMed ID: 32629787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and HDAC inhibitory activity of isosteric thiazoline-oxazole largazole analogs.
    Guerra-Bubb JM; Bowers AA; Smith WB; Paranal R; Estiu G; Wiest O; Bradner JE; Williams RM
    Bioorg Med Chem Lett; 2013 Nov; 23(21):6025-8. PubMed ID: 24035339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis for histone acetylation of human colon cancer cells treated with a novel HDAC inhibitor.
    Zhao Y; Fang X; Wang Y; Zhang J; Jiang S; Liu Z; Ma Z; Xu L; Li E; Zhang K
    Curr Pharm Des; 2014; 20(11):1866-73. PubMed ID: 23888955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of largazole zinc-binding group analogs.
    Kim B; Ratnayake R; Lee H; Shi G; Zeller SL; Li C; Luesch H; Hong J
    Bioorg Med Chem; 2017 Jun; 25(12):3077-3086. PubMed ID: 28416100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Largazole Analogues Embodying Radical Changes in the Depsipeptide Ring: Development of a More Selective and Highly Potent Analogue.
    Almaliti J; Al-Hamashi AA; Negmeldin AT; Hanigan CL; Perera L; Pflum MK; Casero RA; Tillekeratne LM
    J Med Chem; 2016 Dec; 59(23):10642-10660. PubMed ID: 27809521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of largazole and derivatives.
    Seiser T; Kamena F; Cramer N
    Angew Chem Int Ed Engl; 2008; 47(34):6483-5. PubMed ID: 18633950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.